Seong Eon Hong
Overview
Explore the profile of Seong Eon Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kong M, Hong S
Onco Targets Ther
. 2016 Dec;
9:7227-7234.
PMID: 27920560
Purpose: Randomized trials showing a clear survival benefit of intensity-modulated radiotherapy (IMRT) over 3-dimensional conformal radiotherapy (3D-CRT) in the treatment of lung cancer are lacking. This study compared the survival...
2.
Kong M, Hong S
J Radiat Res
. 2016 Oct;
58(2):232-237.
PMID: 27738079
The aim of this study was to describe the patterns of tumor regression with respect to follow-up duration after chemoradiotherapy in patients with nasopharyngeal carcinoma. A total of 27 patients...
3.
Kang J, Hong S, Kang D
Cancer Res Treat
. 2015 Dec;
35(5):440-4.
PMID: 26680971
Purpose: The present study was designed to analyze the relationship between vascular endothelial growth factor (VEGF) and p53, and their impact on clinical outcome in squamous cell carcinoma of the...
4.
Kong M, Hong S
Clin Exp Otorhinolaryngol
. 2015 Dec;
8(4):416-21.
PMID: 26622964
Objectives: We describe patterns of tumor regression based on follow-up duration after radiotherapy (RT) or chemo-RT in patients with head and neck squamous cell carcinoma. Methods: Thirty-one patients with head...
5.
Kong M, Hong S
Chin J Cancer
. 2014 Nov;
34(2):79-85.
PMID: 25418189
The time to complete or partial (objective) response to radiotherapy in patients with hepatocellular carcinoma (HCC) is variable; thus, the reported frequency of these responses depends on the length of...
6.
Jung J, Kong M, Hong S
Onco Targets Ther
. 2014 Oct;
7:1769-75.
PMID: 25328410
Background: The purpose of this study was to evaluate clinical outcomes of conventional fractionated helical tomotherapy in patients with small to medium hepatocellular carcinomas (HCCs) without portal vein tumor thrombosis....
7.
Kong M, Hong S, Chang S
Onco Targets Ther
. 2014 Apr;
7:553-66.
PMID: 24748805
Background: This study is a report on the long-term analysis of acute and late toxicities for patients with localized prostate cancer treated with hypofractionated helical tomotherapy. Methods: From January 2008...
8.
Kong M, Hong S
Asian Pac J Cancer Prev
. 2014 Mar;
15(4):1545-9.
PMID: 24641365
Background: Published studies on clinical outcome of helical tomotherapy for lung cancer are limited. The purpose of this study was to evaluate clinical outcomes and treatment-related toxicity in inoperable non-small...
9.
Kim Y, Hong S, Kong M, Choi J
Cancer Res Treat
. 2014 Jan;
45(4):295-302.
PMID: 24454002
Purpose: Predictive factors for radiation pneumonitis (RP) after helical tomotherapy (HT) may differ from those after linac-based radiotherapy. In this study, we identified predictive factors for RP in patients with...
10.
Kong M, Hong S
Asian Pac J Cancer Prev
. 2013 Oct;
14(8):4859-64.
PMID: 24083759
Background: The purpose of this study was to assess the effectiveness of a recombinant human epidermal growth factor (EGF)-based cream for the prevention of acute radiation dermatitis in breast cancer...